Abstract
Recent results obtained from the genotyping of 50 patients who received hematopoietic stem cell transplantation (HSCT) for onco-hematological treatment from related donors, HLA compatible, without depletion of T lymphocytes and assisted in the Center of Hematology University of Campinas, indicate an increase in overall survival of patients in whom we observed the presence of HLA class I l…